Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| type I pneumocyte | 10 studies | 37% ± 13% | |
| type II pneumocyte | 4 studies | 31% ± 5% | |
| pancreatic A cell | 4 studies | 48% ± 22% | |
| ciliated cell | 4 studies | 19% ± 4% | |
| retinal ganglion cell | 3 studies | 47% ± 10% | |
| epithelial cell | 3 studies | 23% ± 3% |
Insufficient scRNA-seq data for expression of IRX2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 99% | 2482.28 | 454 / 459 | 90% | 53.83 | 1010 / 1118 |
| prostate | 91% | 523.61 | 222 / 245 | 98% | 18.02 | 493 / 502 |
| lung | 97% | 2007.04 | 560 / 578 | 72% | 24.91 | 837 / 1155 |
| skin | 100% | 2730.07 | 1809 / 1809 | 26% | 3.65 | 121 / 472 |
| esophagus | 37% | 201.98 | 539 / 1445 | 83% | 37.62 | 151 / 183 |
| stomach | 74% | 1434.94 | 264 / 359 | 46% | 12.89 | 132 / 286 |
| thymus | 59% | 219.00 | 388 / 653 | 48% | 12.82 | 289 / 605 |
| kidney | 83% | 1096.04 | 74 / 89 | 4% | 0.50 | 38 / 901 |
| brain | 25% | 107.07 | 653 / 2642 | 52% | 7.24 | 370 / 705 |
| adipose | 54% | 307.46 | 654 / 1204 | 0% | 0 | 0 / 0 |
| intestine | 0% | 2.59 | 3 / 966 | 48% | 10.86 | 255 / 527 |
| tonsil | 0% | 0 | 0 / 0 | 44% | 7.70 | 20 / 45 |
| uterus | 0% | 0 | 0 / 170 | 37% | 10.46 | 171 / 459 |
| bladder | 0% | 0 | 0 / 21 | 25% | 4.43 | 126 / 504 |
| pancreas | 7% | 27.78 | 24 / 328 | 15% | 7.49 | 27 / 178 |
| heart | 7% | 27.28 | 59 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 6% | 26.49 | 85 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 1.59 | 1 / 258 | 5% | 0.78 | 12 / 230 |
| ovary | 1% | 2.55 | 1 / 180 | 3% | 0.26 | 13 / 430 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.16 | 2 / 80 |
| liver | 0% | 0 | 0 / 226 | 2% | 0.14 | 9 / 406 |
| peripheral blood | 0% | 0.28 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030182 | Biological process | neuron differentiation |
| GO_0072086 | Biological process | specification of loop of Henle identity |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0048468 | Biological process | cell development |
| GO_0072272 | Biological process | proximal/distal pattern formation involved in metanephric nephron development |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| GO_0043565 | Molecular function | sequence-specific DNA binding |
| Gene name | IRX2 |
| Protein name | Iroquois-class homeodomain protein IRX-2 (Homeodomain protein IRXA2) (Iroquois homeobox protein 2) |
| Synonyms | IRXA2 |
| Description | |
| Accessions | ENST00000302057.6 Q9BZI1 ENST00000382611.10 |
